Coronavirus (COVID-19)

Special Arrangements

For Entrepreneurs

We have spent a lot of time over the last few weeks preparing our NovaUCD and Nexus buildings to reopen. Implementing clear signage, distance markings, sanitisation points, one-way systems, deep cleans, perspex screens, washing, cleaning and training. We are taking every precaution to ensure our community have a safe return to campus in line with Government’s back to work safety protocol.

While Covid-19 has been challenging for everyone in different ways, we are excited about more positive days ahead. Some of the most iconic companies of the next decade will be launched during these uncertain times. At NovaUCD, we are seeking applications from entrepreneurs with groundbreaking technologies with high impact who want to join our community.

[button title="Find Out More" url="" color="tile-yellow"]

Stay safe and see you soon.

A Guide to Covid-19 Business Supports and Resources

For Researchers

The Knowledge Transfer Office is operating business as usual and can be contacted via the usual channels.

NovaUCD’s innovation programmes are currently being delivered online. Our Commercialisation Bootcamp, Customer Discovery Programme and Venture Launch Accelerator are all running virtually for the remainder of 2020.

ConsultUCD are operating as normal and can be contacted on the usual emails and phone numbers.


For Students

UCD Formula Student (UCDFS) has been declared overall winner of the 2020 NovaUCD Student Enterprise Competition and has won a €5,000 cash prize.

UCDFS is a team of over 50 University College Dublin (UCD) engineering and business students who are working together to build an electric Formula-1 style car to compete in the Formula Student competition held annually at the iconic Silverstone Circuit in the UK.

[button title="Find Out More" url=",501271,en.html" color="tile-yellow"]

Virtual Events

Supporting our Start-Up Ecosystem

Our Partners' offers include Consultations, Discounts and Credits

Find out more about how the UCD community is rising to the challenge posed by COVID-19